- Home
- SVRA vs OKLO Comparison
SVRA vs OKLO Comparison
Compare SVRA & OKLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- OKLO
- Stock Information
- Founded
- SVRA N/A
- OKLO 2013
- Country
- SVRA United States
- OKLO United States
- Employees
- SVRA N/A
- OKLO N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- OKLO
- Sector
- SVRA Health Care
- OKLO
- Exchange
- SVRA Nasdaq
- OKLO NYSE
- Market Cap
- SVRA 552.6M
- OKLO 710.6M
- IPO Year
- SVRA N/A
- OKLO N/A
- Fundamental
- Price
- SVRA $3.24
- OKLO $25.25
- Analyst Decision
- SVRA Buy
- OKLO Buy
- Analyst Count
- SVRA 6
- OKLO 2
- Target Price
- SVRA $10.83
- OKLO $10.00
- AVG Volume (30 Days)
- SVRA 2.0M
- OKLO 21.9M
- Earning Date
- SVRA 11-12-2024
- OKLO 11-14-2024
- Dividend Yield
- SVRA N/A
- OKLO N/A
- EPS Growth
- SVRA N/A
- OKLO N/A
- EPS
- SVRA N/A
- OKLO N/A
- Revenue
- SVRA N/A
- OKLO N/A
- Revenue This Year
- SVRA N/A
- OKLO N/A
- Revenue Next Year
- SVRA N/A
- OKLO N/A
- P/E Ratio
- SVRA N/A
- OKLO N/A
- Revenue Growth
- SVRA N/A
- OKLO N/A
- 52 Week Low
- SVRA $2.82
- OKLO $5.35
- 52 Week High
- SVRA $5.70
- OKLO $28.12
- Technical
- Relative Strength Index (RSI)
- SVRA 41.82
- OKLO 60.46
- Support Level
- SVRA $2.82
- OKLO $19.53
- Resistance Level
- SVRA $4.30
- OKLO $22.54
- Average True Range (ATR)
- SVRA 0.30
- OKLO 3.25
- MACD
- SVRA -0.05
- OKLO -0.46
- Stochastic Oscillator
- SVRA 28.72
- OKLO 76.00
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About OKLO OKLO INC
Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.